BACKBLAZE INC-A (BLZE)

US05637B1052 - Common Stock

6.19  +0.01 (+0.16%)

Fundamental Rating

2

Taking everything into account, BLZE scores 2 out of 10 in our fundamental rating. BLZE was compared to 86 industry peers in the IT Services industry. BLZE may be in some trouble as it scores bad on both profitability and health. BLZE shows excellent growth, but is valued quite expensive already.



1

1. Profitability

1.1 Basic Checks

BLZE had negative earnings in the past year.
In the past year BLZE had a positive cash flow from operations.
In the past 5 years BLZE always reported negative net income.
In multiple years BLZE reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -38.87%, BLZE is doing worse than 89.16% of the companies in the same industry.
With a Return On Equity value of -110.14%, BLZE is not doing good in the industry: 77.11% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -38.87%
ROE -110.14%
ROIC N/A
ROA(3y)-30.77%
ROA(5y)-21.41%
ROE(3y)-76.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BLZE's Gross Margin of 51.93% is fine compared to the rest of the industry. BLZE outperforms 73.49% of its industry peers.
BLZE's Gross Margin has declined in the last couple of years.
BLZE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.06%
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

BLZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BLZE has been increased compared to 1 year ago.
Compared to 1 year ago, BLZE has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.45, we must say that BLZE is in the distress zone and has some risk of bankruptcy.
BLZE has a Altman-Z score of -0.45. This is in the lower half of the industry: BLZE underperforms 79.52% of its industry peers.
BLZE has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.34, BLZE perfoms like the industry average, outperforming 57.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z -0.45
ROIC/WACCN/A
WACC9.87%

2.3 Liquidity

A Current Ratio of 0.61 indicates that BLZE may have some problems paying its short term obligations.
With a Current ratio value of 0.61, BLZE is not doing good in the industry: 89.16% of the companies in the same industry are doing better.
A Quick Ratio of 0.61 indicates that BLZE may have some problems paying its short term obligations.
BLZE has a worse Quick ratio (0.61) than 87.95% of its industry peers.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.61

7

3. Growth

3.1 Past

BLZE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.80%, which is quite impressive.
BLZE shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.02%.
Measured over the past years, BLZE shows a very strong growth in Revenue. The Revenue has been growing by 23.79% on average per year.
EPS 1Y (TTM)35.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.02%
Revenue 1Y (TTM)24.02%
Revenue growth 3Y23.79%
Revenue growth 5YN/A
Sales Q2Q%27.23%

3.2 Future

The Earnings Per Share is expected to grow by 22.34% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 20.69% on average over the next years. This is a very strong growth
EPS Next Y39.86%
EPS Next 2Y22.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25.66%
Revenue Next 2Y20.69%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

BLZE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BLZE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as BLZE's earnings are expected to grow with 22.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.34%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BLZE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BACKBLAZE INC-A

NASDAQ:BLZE (9/16/2024, 3:08:03 PM)

6.19

+0.01 (+0.16%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap265.55M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.87%
ROE -110.14%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 51.93%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.61
Quick Ratio 0.61
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)35.8%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y39.86%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)24.02%
Revenue growth 3Y23.79%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y